Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
HALO
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
HALO: Halozyme Therapeutics, Inc. Stock Analysis | finqOS
HALO
$91.35
−1.82%
Lists
Call HALO
Halozyme Therapeutics
HALO
Back
Lists
Call HALO
$91.35
−$1.69 · −1.82%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
16%
in three months and
41%
of the way up its 52-week range.
Call HALO
Loading chart data...
Signal state